Cannvas MedTech (CSE:MTEC) (“Cannvas” or the “Company”), a leading business technology company in the cannabis space, is pleased to announce that its senior management team will be attending Extraordinary Future 2018 on September 19-20 in Vancouver, BC. Extraordinary Future 2018 is an excellent opportunity to showcase Canadian technologies to the investment community. The Cannvas executive team will be available for meetings in Booth #708 where CEO Shawn Moniz and COO Steve Loutskou will be in attendance. Mr. Moniz will also deliver an investor presentation on September 20th at 12:10 pm.
|Event:||Extraordinary Future 2018|
|Date:||Thursday, September 20, 2018|
|Presentation:||12:10 – 12:20pm PT, Workshop 1|
|Venue:||Vancouver Convention Centre East, 999 Canada Place, Vancouver, BC|
|Event Hours:||9:00am – 6:00pm|
Produced by Cambridge House International and held at the Vancouver Convention Centre, the two-day conference focuses on innovative technologies and offers attendees the chance to connect with entrepreneurs, investors, and innovators. The theme of the conference is to explore ideas that will directly impact the “the extraordinary future of science and life.” To that end, topics to be discussed include:
- Cannabis Delivery Systems
- Mental Health and Longevity
- Startup Competition
- Battery Technology
- Blockchain & the Music Industry
- Tokenized Securities
- Quantum Computing
- Data Warfare
Extraordinary Future features a tradeshow exhibition, one-on-one meetings with investors, presentations, keynote speakers, and much more.
To register and for more information visit: www.extraordinaryfuture.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
For additional information:
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.
For further information: Media Inquiries: firstname.lastname@example.org; Investor Relations: email@example.com, 1-800-489-0116
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).